John R. Pullman

2.7k citations
33 papers · 2.1k · 2 hit papers · h-index 19

Impact in

Papers in

    • Antimicrobial Resistance in Staphylococcus 9
    • Clostridium difficile and Clostridium perfringens research 6
    • Antifungal resistance and susceptibility 4
    • Bacterial Infections and Vaccines 3

John R. Pullman

33 papers receiving 2.0k citations

John R. Pullman's Hit Papers

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial 2019 · 357 citations
3570+5+10Years since publication100200300

Peers

John R. Pullman
Comparison fields: 5 of 90
  • Endocrinology, Diabetes and Metabolism 763
  • Infectious Diseases 734
  • Applied Microbiology and Biotechnology 59
  • Molecular Medicine 131
  • Clinical Biochemistry 172
Replace Purvi Mehra with:
Purvi Mehra United States
Massimiliano De Angelis Italy
Francesca Crea Italy
Alessandro Perrella Italy
H. G. de Vries-Hospers Netherlands
Hassan Gandjini France
Habip Gedık Türkiye
Hjalmar Lagast Belgium
Luís Coelho Portugal
Marie‐Françoise Tripodi Italy
John R. Pullman relative to Purvi Mehra United States Purvi Mehra's profile →
Citations per field
00.5×2×2.7×
Purvi Mehra · 1×
Citations per year

Countries citing papers authored by John R. Pullman

Since Specialization
Citations

This map shows the geographic impact of John R. Pullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Pullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Pullman more than expected).

Fields of papers citing papers by John R. Pullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Pullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Pullman. The network helps show where John R. Pullman may publish in the future.

Co-authors

The 25 scholars most cited alongside John R. Pullman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John R. Pullman Line = papers co-authored together John R. Pullman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
Hit paper breakdown →
2011390
2
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Hit paper breakdown →
2019357
3 2010190
4 2005108
5 2017105
6 201791
7 201891
8 201972
9 199869
10 201569
11 202368
12 200764
13 201460
14 201958
15 200648
16 200344
17 202325
18 201824
19 200322
20 201819

About John R. Pullman

John R. Pullman is a scholar working on Infectious Diseases, Microbiology, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 33 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (9 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Diabetes Treatment and Management (4 papers), Antifungal resistance and susceptibility (4 papers), Pneumonia and Respiratory Infections (3 papers), Streptococcal Infections and Treatments (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Bacterial Infections and Vaccines (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (763 citations), Infectious Diseases (734 citations), Applied Microbiology and Biotechnology (59 citations), Molecular Medicine (131 citations) and Clinical Biochemistry (172 citations). John R. Pullman has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Lisa Ann Porter, Christine T. Schulteis, Thomas Blevins, Jaret L. Malloy, Ping Yan, Kristin Taylor, MICHAEL E. TRAUTMANN, Sue Cammarata, Laura E. Lawrence and Tamara Darsow. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Open Forum Infectious Diseases, Clinical Infectious Diseases, JAMA Network Open and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact